Related Experiment Video

Updated: Oct 13, 2025

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
04:44

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease

Published on: June 16, 2020

20.3K

The Association between Sarcoidosis and Ischemic Heart Disease-A Healthcare Analysis of a Large Israeli Population

Tal Gonen1,2, Daphna Katz-Talmor3,4, Howard Amital1,2,4

  • 1Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv 6997801, Israel.

Journal of Clinical Medicine
|November 13, 2021
PubMed

Insights

Sarcoidosis patients have a 50% higher risk of ischemic heart disease (IHD). This chronic inflammatory condition also significantly increases the risk of all-cause mortality in affected individuals.

Area of Science:

  • Cardiology
  • Rheumatology
  • Public Health

Background:

  • Inflammation is a key factor in atherosclerosis.
  • Chronic inflammatory diseases, such as rheumatic conditions, are linked to ischemic heart disease (IHD).
  • Sarcoidosis, a systemic inflammatory disease, may also pose an increased risk for IHD.

Purpose of the Study:

  • To investigate the association between sarcoidosis and the risk of developing IHD.
  • To evaluate the long-term mortality risk in sarcoidosis patients compared to controls.

Main Methods:

  • Retrospective cohort study using data from 3750 sarcoidosis patients and 18,139 matched controls.
  • Logistic regression analysis to assess IHD risk factors.
  • Cox proportional hazards model and log-rank test for survival and mortality analysis.

Main Results:

  • Sarcoidosis patients demonstrated a 1.5-fold increased odds of IHD (OR 1.5; 95% CI 1.36-1.66).
  • Sarcoidosis patients had significantly higher all-cause mortality (15% vs. 9%; p < 0.001).
  • Survival analysis indicated a 1.93-fold increased hazard for all-cause mortality in sarcoidosis patients (HR 1.93; 95% CI 1.76-2.13).

Conclusions:

  • Sarcoidosis is independently associated with an increased risk of ischemic heart disease.
  • Sarcoidosis patients face a substantially higher risk of all-cause mortality.
  • These findings highlight the importance of cardiovascular risk assessment and management in sarcoidosis.

Keywords:
comorbiditiesischemic heart diseasesarcoidosis

More Related Videos

Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma10:21

Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma

Published on: September 20, 2024

569
Optical Coherence Tomography Based Biomechanical Fluid-Structure Interaction Analysis of Coronary Atherosclerosis Progression13:07

Optical Coherence Tomography Based Biomechanical Fluid-Structure Interaction Analysis of Coronary Atherosclerosis Progression

Published on: January 15, 2022

4.1K

Related Concept Videos

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
116
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
2.0K
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
90
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
71
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
81
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
54